KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Cash & Current Investments (2016 - 2026)

Abbott Laboratories' Cash & Current Investments history spans 18 years, with the latest figure at $7.3 billion for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 6.59% to $7.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $7.3 billion, a 6.59% increase, with the full-year FY2025 number at $8.9 billion, up 12.2% from a year prior.
  • Cash & Current Investments hit $7.3 billion in Q1 2026 for Abbott Laboratories, down from $8.9 billion in the prior quarter.
  • Over the last five years, Cash & Current Investments for ABT hit a ceiling of $10.2 billion in Q4 2022 and a floor of $6.7 billion in Q1 2024.
  • Historically, Cash & Current Investments has averaged $8.1 billion across 5 years, with a median of $7.8 billion in 2024.
  • Biggest five-year swings in Cash & Current Investments: rose 16.84% in 2023 and later crashed 30.22% in 2024.
  • Tracing ABT's Cash & Current Investments over 5 years: stood at $10.2 billion in 2022, then fell by 28.43% to $7.3 billion in 2023, then increased by 9.45% to $8.0 billion in 2024, then rose by 12.2% to $8.9 billion in 2025, then fell by 18.39% to $7.3 billion in 2026.
  • Business Quant data shows Cash & Current Investments for ABT at $7.3 billion in Q1 2026, $8.9 billion in Q4 2025, and $7.7 billion in Q3 2025.